Report cover image

Asia-pacific Ophthalmic Drugs Market Forecast 2023-2032

Publisher Inkwood Research
Published Nov 17, 2023
Length 172 Pages
SKU # INKR18381620

Description

Asia-pacific Ophthalmic Drugs Market Forecast 2023-2032



KEY FINDINGS

The Asia-Pacific ophthalmic drugs market is set to project a CAGR of 7.06% during the forecast period, 2023-2032. The expansion of the market is fueled by rising healthcare budgets and heightened investments in eye care services throughout the Asia-Pacific region, which enhance the availability and accessibility of ophthalmic drugs.

MARKET INSIGHTS

Vietnam, Australia & New Zealand, Thailand, China, Japan, South Korea, Indonesia, India, and Rest of Asia-Pacific are analyzed for the Asia-Pacific ophthalmic drugs market growth evaluation. The aging population in Japan stands out as a crucial factor propelling the Ophthalmic drugs market in the country. With a progressively increasing elderly demographic, Japan is witnessing a surge in age-related eye disorders such as cataracts, glaucoma, and age-related macular degeneration (AMD). This demographic transition is driving the demand for ophthalmic drugs aimed at managing and treating these prevalent conditions.

The growth of the market is significantly influenced by Japan's esteemed healthcare system. Recognized for its excellence, the Japanese healthcare system plays a pivotal role in fostering market expansion. The government of Japan actively advocates for healthcare research and development, leading to the creation of a multitude of ophthalmic drugs known for their effectiveness and adherence to the highest quality standards. The relentless pursuit of superior eye care has positioned Japan at the forefront of developing cutting-edge pharmaceuticals.

India is currently experiencing a rise in the incidence of eye disorders, such as cataracts, glaucoma, and age-related macular degeneration. This trend is attributed to factors like the aging population and lifestyle choices. The expansion of the country's healthcare infrastructure, including the establishment of eye care clinics and hospitals, has improved the availability of ophthalmic treatments, thereby bolstering the market. Ophthalmic drug manufacturers are placing emphasis on innovation by developing advanced formulations like preservative-free eye drops, extended-release implants, and combination therapies to offer effective treatment options.

COMPETITIVE INSIGHTS

Some of the key companies in the market are Regeneron Pharmaceuticals Inc, Sun Pharmaceutical Industries Ltd, Santen Pharmaceutical Co Ltd, etc.

Our report offerings include:
  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


      • Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

172 Pages
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
2.3. Scope Of Study
2.4. Crisis Scenario Analysis
2.4.1. Impact Of Covid-19 On Ophthalmic Drugs Market
2.5. Major Market Findings
2.5.1. Emerging Therapies For Dry Eye Syndrome
2.5.2. Growing Demand For Combination Therapies
2.5.3. Increasing Investment In Research & Development
2.5.4. Shift Toward Over-the-counter (Otc) Products
3. Market Dynamics
3.1. Key Drivers
3.1.1. Aging Population's Susceptibility To Age-related Eye Conditions
3.1.2. Advancements In Drug Delivery Technologies
3.1.3. Rising Prevalence Of Eye Diseases And Disorders
3.1.4. Favorable Reimbursement Policies By Healthcare Systems
3.2. Key Restraints
3.2.1. Delay In Drug Approvals
3.2.2. Side Effects Related To Ophthalmic Drugs
4. Key Analytics
4.1. Key Market Trends
4.2. Technology Snapshot
4.2.1. Biologics
4.2.2. Cell Therapy
4.2.3. Gene Therapy
4.2.4. Drug Delivery
4.2.5. Small Molecule
4.2.6. Other Technologies
4.3. Porter's Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Growth Prospect Mapping
4.5. Market Maturity Analysis
4.6. Market Concentration Analysis
4.7. Key Buying Criteria
4.8. Regulatory Framework
5. Market By Indication
5.1. Dry Eye
5.2. Glaucoma
5.3. Infection/Inflammation/Allergies
5.4. Retinal Disorder
5.4.1. Wet Age-related Macular Degeneration
5.4.2. Dry Age-related Macular Degeneration
5.4.3. Diabetic Retinopathy
5.4.4. Other Retinal Disorders
5.5. Other Indications
6. Market By Type
6.1. Prescription Drugs
6.2. Over-the-counter Drugs
7. Market By Dosage Form
7.1. Gels
7.2. Eye Solutions & Suspensions
7.3. Capsules & Tablets
7.4. Eye Drops
7.5. Ointments
8. Market By Therapeutic Class
8.1. Anti-glaucoma
8.2. Anti-infection
8.3. Anti-inflammatory
8.4. Anti-allergy
8.5. Other Therapeutic Classes
9. Market By Distribution Channel
9.1. Hospital Pharmacies
9.2. Drug Stores
9.3. Online Pharmacies
9.4. Other Distribution Channels
10. Geographical Analysis
10.1. Asia-pacific
10.1.1. Market Size & Estimates
10.1.2. Asia-pacific Ophthalmic Drugs Market Drivers
10.1.3. Asia-pacific Ophthalmic Drugs Market Challenges
10.1.4. Key Players In Asia-pacific Ophthalmic Drugs Market
10.1.5. Country Analysis
10.1.5.1. China
10.1.5.1.1. China Ophthalmic Drugs Market Size & Opportunities
10.1.5.2. Japan
10.1.5.2.1. Japan Ophthalmic Drugs Market Size & Opportunities
10.1.5.3. India
10.1.5.3.1. India Ophthalmic Drugs Market Size & Opportunities
10.1.5.4. South Korea
10.1.5.4.1. South Korea Ophthalmic Drugs Market Size & Opportunities
10.1.5.5. Indonesia
10.1.5.5.1. Indonesia Ophthalmic Drugs Market Size & Opportunities
10.1.5.6. Thailand
10.1.5.6.1. Thailand Ophthalmic Drugs Market Size & Opportunities
10.1.5.7. Vietnam
10.1.5.7.1. Vietnam Ophthalmic Drugs Market Size & Opportunities
10.1.5.8. Australia & New Zealand
10.1.5.8.1. Australia & New Zealand Ophthalmic Drugs Market Size & Opportunities
10.1.5.9. Rest Of Asia-pacific
10.1.5.9.1. Rest Of Asia-pacific Ophthalmic Drugs Market Size & Opportunities
11. Competitive Landscape
11.1. Key Strategic Developments
11.1.1. Mergers & Acquisitions
11.1.2. Product Launches & Developments
11.1.3. Partnerships & Agreements
11.2. Company Profiles
11.2.1. Abbvie Inc
11.2.1.1. Company Overview
11.2.1.2. Products & Services
11.2.1.3. Strengths & Challenges
11.2.2. Accutome Inc
11.2.2.1. Company Overview
11.2.2.2. Products & Services
11.2.2.3. Strengths & Challenges
11.2.3. Bausch Health Companies Inc
11.2.3.1. Company Overview
11.2.3.2. Products & Services
11.2.3.3. Strengths & Challenges
11.2.4. Genentech Inc
11.2.4.1. Company Overview
11.2.4.2. Products & Services
11.2.4.3. Strengths & Challenges
11.2.5. Johnson & Johnson
11.2.5.1. Company Overview
11.2.5.2. Products & Services
11.2.5.3. Strengths & Challenges
11.2.6. Thea Pharma Inc
11.2.6.1. Company Overview
11.2.6.2. Products & Services
11.2.6.3. Strengths & Challenges
11.2.7. Novartis Ag
11.2.7.1. Company Overview
11.2.7.2. Products & Services
11.2.7.3. Strengths & Challenges
11.2.8. Pfizer Inc
11.2.8.1. Company Overview
11.2.8.2. Products & Services
11.2.8.3. Strengths & Challenges
11.2.9. Regeneron Pharmaceuticals Inc
11.2.9.1. Company Overview
11.2.9.2. Products & Services
11.2.9.3. Strengths & Challenges
11.2.10. Santen Pharmaceutical Co Ltd
11.2.10.1. Company Overview
11.2.10.2. Products & Services
11.2.10.3. Strengths & Challenges
11.2.11. Sun Pharmaceutical Industries Ltd
11.2.11.1. Company Overview
11.2.11.2. Products & Services
11.2.11.3. Strengths & Challenges
11.2.12. Teva Pharmaceuticals Industries Ltd
11.2.12.1. Company Overview
11.2.12.2. Products & Services
11.2.12.3. Strengths & Challenges

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us